x
Filter:
Filters applied
- ACMG Statements and Guidelines
- David, Karen LRemove David, Karen L filter
- variant reclassificationRemove variant reclassification filter
Publication Date
Please choose a date range between 2019 and 2019.
ACMG Statements and Guidelines
These online statements and guidelines are definitive and may be cited using the digital object identifier (DOI). These recommendations are designed primarily as an educational resource for medical geneticists and other healthcare providers to help them provide quality medical genetics services; they should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed to obtaining the same results. Please refer to the leading disclaimer in each document for more information.
1 Results
- ACMG Policy StatementOpen Archive
Patient re-contact after revision of genomic test results: points to consider—a statement of the American College of Medical Genetics and Genomics (ACMG)
Genetics in MedicineVol. 21Issue 4p769–771Published in issue: April, 2019- Karen L. David
- Robert G. Best
- Leslie Manace Brenman
- Lynn Bush
- Joshua L. Deignan
- David Flannery
- and others
Cited in Scopus: 67Nearly two decades ago, the American College of Medical Genetics (now the American College of Medical Genetics and Genomics [ACMG]) Policy Statement “Duty to re-contact” was prescient in highlighting the increasingly important issue of patient re-contact.1 Originally focused on clinical genetics practice, its importance now extends to both medical genomics and medical practice in general. Next-generation genomic testing, including multigene panels, exome sequencing (ES), and genome sequencing (GS), is permitting ever larger amounts of data to be collected on each patient sample, with a corresponding increase in the complexity of the results.
